Oxidative Medicine and Cellular Longevity / 2015 / Article / Fig 3

Research Article

Integrated Haematological Profiles of Redox Status, Lipid, and Inflammatory Protein Biomarkers in Benign Obesity and Unhealthy Obesity with Metabolic Syndrome

Figure 3

Selected representative parameters describing fatty acid profile of erythrocyte membrane phospholipids: ratio saturated/monounsaturated fatty acids (a), ratio ω6/ω3 polyunsaturated fatty acids (b), ω6-arachidonic acid percent of total FA content of phospholipids (c), and ω-3 eicosapentaenoic acid % of total FA content of phospholipids (d), in the groups of obese patients with metabolic syndrome (OB w.MetS, ) and without metabolic syndrome (OB w.o.MetS, ) and of control healthy subjects (CTR, ). Values are represented as mean (□), standard error of the mean (upper and lower limits of the box), and 1.96 × standard error (upper and lower whiskers). Intergroup significant differences () are indicated in each panel. Abbreviations: SAT (saturated fatty acids); MUFA (monounsaturated fatty acids); PUFA (polyunsaturated fatty acids); C20:4 (arachidonic acid); C20:5 (eicosapentaenoic acid); and RBC (red blood cells). Techniques: gas chromatography-mass spectrometry with selected ion monitoring (a–d).

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.